A Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of JNJ-63623872 in Combination With Oseltamivir in Adult, and Elderly Hospitalized Participants With Influenza A Infection

NCT02532283 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A Virus

Interventions

DRUG: JNJ-63623872
DRUG: Placebo
DRUG: Oseltamivir

Sponsor

Janssen Research & Development, LLC